Table 3.
No. | Ingredient | PACa | Eb (%) | Z. mays Specific Primer Ct ± SD | A/D | |||
---|---|---|---|---|---|---|---|---|
C. longa (%) | Z. mays (%) | ZM_matK | ZM_atpF | ZM_ycf2 | ||||
1 | 99 | 1 | 13.57 ± 0.04 | 0.5–1.5 | 25.02 ± 0.06 | 25.61 ± 0.20 | 26.44 ± 0.21 | Ad |
2 | 98 | 2 | 14.73 ± 0.09 | 1–5 | 25.09 ± 0.02 | 24.78 ± 0.12 | 22.8 ± 0.18 | A |
3 | 100 | 0 | 14.03 ± 0.01 | NDc | 31.51 ± 0.15 | 31.32 ± 0.26 | 35.15 ± 0.05 | A |
4 | 98 | 2 | 14.31 ± 0.01 | 1–5 | 24.40 ± 0.01 | 24.75 ± 0.15 | 23.92 ± 0.09 | A |
5 | 95 | 5 | 14.05 ± 0.01 | 1–5 | 23.72 ± 0.09 | 24.34 ± 0.09 | 21.94 ± 0.22 | A |
6 | 97 | 3 | 14.11 ± 0.06 | 1–5 | 23.45 ± 0.05 | 24.90 ± 0.07 | 22.97 ± 0.25 | A |
7 | 99.5 | 0.5 | 14.21 ± 0.02 | 0.5–1.5 | 25.09 ± 0.05 | 26.95 ± 0.07 | 26.34 ± 0.15 | A |
8 | 98.5 | 1.5 | 14.12 ± 0.05 | 0.5–1.5 | 25.59 ± 0.03 | 26.32 ± 0.10 | 24.69 ± 0.19 | A |
9 | 100 | 0 | 14.33 ± 0.08 | ND | 31.67 ± 0.20 | 31.01 ± 0.80 | 34.89 ± 0.10 | A |
10 | 98.5 | 1.5 | 14.23 ± 0.03 | 0.3–2 | 25.13 ± 0.09 | 25.69 ± 0.10 | 24.21 ± 0.02 | A |
11 | 99.5 | 0.5 | 14.27 ± 0.01 | 0.1–1 | 26.06 ± 0.09 | 27.08 ± 0.10 | 26.19 ± 0.09 | A |
12 | 100 | 0 | 13.61 ± 0.12 | ND | 31.33 ± 0.28 | 30.98 ± 0.11 | 34.46 ± 0.26 | A |
13 | 97 | 3 | 14.31 ± 0.10 | 1–5 | 24.97 ± 0.09 | 24.37 ± 0.07 | 23.86 ± 0.13 | A |
14 | 98 | 2 | 13.22 ± 0.07 | 1–5 | 24.19 ± 0.09 | 26.14 ± 0.12 | 23.22 ± 0.09 | A |
15 | 96 | 4 | 13.33 ± 0.06 | 1–5 | 23.92 ± 0.15 | 24.26 ± 0.03 | 22.72 ± 0.27 | A |
16 | 99 | 1 | 14.26 ± 0.05 | 0.1–1 | 25.75 ± 0.10 | 26.75 ± 0.14 | 25.11 ± 0.10 | A |
17 | 93 | 7 | 13.95 ± 0.07 | 5–10 | 22.11 ± 0.11 | 23.99 ± 0.13 | 21.72 ± 0.11 | A |
18 | 90 | 10 | 13.74 ± 0.02 | 10–15 | 22.11 ± 0.10 | 21.99 ± 0.18 | 21.23 ± 0.13 | A |
19 | 100 | 0 | 16.21 ± 0.07 | ND | 30.82 ± 0.20 | 31.09 ± 0.01 | 34.06 ± 0.56 | A |
20 | 97 | 3 | 13.27 ± 0.1 | 1–5 | 23.96 ± 0.05 | 24.28 ± 0.10 | 23.22 ± 0.12 | A |
a Positive amplification control (18s rRNA); b, expected ratio of the Z. mays; C, not detected; d accordance.